Format

Send to:

Choose Destination
See comment in PubMed Commons below
Radiat Oncol. 2012 Feb 1;7:16. doi: 10.1186/1748-717X-7-16.

Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerations.

Author information

  • 1IRCCS Istituto Clinico Humanitas, Rozzano (Milano), Italy. pietro.mancosu@humanitas.it

Abstract

PURPOSE:

To report the initial institute experience in terms of dosimetric and technical aspects in stereotactic body radiation therapy (SBRT) delivered using flattening filter free (FFF) beam in patients with liver lesions.

METHODS AND MATERIALS:

From October 2010 to September 2011, 55 consecutive patients with 73 primary or metastatic hepatic lesions were treated with SBRT on TrueBeam using FFF beam and RapidArc technique. Clinical target volume (CTV) was defined on multi-phase CT scans, PET/CT, MRI, and 4D-CT. Dose prescription was 75 Gy in 3 fractions to planning target volume (PTV). Constraints for organs at risk were: 700 cc of liver free from the 15 Gy isodose, Dmax < 21 Gy for stomach and duodenum, Dmax < 30 Gy for heart, D0.1 cc < 18 Gy for spinal cord, V15 Gy < 35% for kidneys. The dose was downscaled in cases of not full achievement of dose constraints. Daily cone beam CT (CBCT) was performed.

RESULTS:

Forty-three patients with a single lesion, nine with two lesions and three with three lesions were treated with this protocol. Target and organs at risk objectives were met for all patients. Mean delivery time was 2.8 ± 1.0 min. Pre-treatment plan verification resulted in a Gamma Agreement Index of 98.6 ± 0.8%. Mean on-line co-registration shift of the daily CBCT to the simulation CT were: -0.08, 0.05 and -0.02 cm with standard deviations of 0.33, 0.39 and 0.55 cm in, vertical, longitudinal and lateral directions respectively.

CONCLUSIONS:

SBRT for liver targets delivered by means of FFF resulted to be feasible with short beam on time.

PMID:
22296849
[PubMed - indexed for MEDLINE]
PMCID:
PMC3292972
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk